About Judith Segall
Form D filings for Phythera Therapeutics in 2024 list Judith Segall as executive officer, director and promoter.
Judith Segall first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Judith Segall in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Judith Segall works with at each company, as listed on that company's latest Form D.
Phythera Therapeutics Inc. · Form D, May 16, 2024
NT
Ngoc Tran
Executive officer and promoter
ID
Igor Nasonkin, Ph.D.
Chief Executive Officer and director
CD
Charles Irving, Ph.D.
Executive officer, director and promoter
HD
Hal Sternberg, Ph.D.
Executive officer, director and promoter
ZN
Zamira Nasonkin
Promoter